RESUMEN
This article reported a case of Inflammatory myofibroblastic tumor of the bladder combined with cystitis glandularis. The patient was admitted to the hospital after hematuria for more than 20 days and occasionally accompanied with dysuria.Preoperative imaging examination showed a space-occupying lesion on the anterior bladder wall, with a size about 7.7 cm×6.1 cm×4.4 cm, considering the possibility of bladder cancer. Laparoscopic robot-assisted partial cystectomy was performed, and the postoperative pathological diagnosis was cystitis myofibroblastic tumor combined with cystitis glandularis. Cystitis myofibroblastic tumor is a true tumor originating from the bladder parenchyma, which is a rare clinical disease, and it combined with cystitis glandularis has not been reported. Because its clinical manifestations and imaging manifestations are difficult to distinguish from bladder malignant tumors, the diagnosis mainly depends on pathology and immunohistochemistry stain.
RESUMEN
Inflammatory myofibroblastoma (IMT) is a rare solid tumor, and its etiology and pathogenesis are unclear. Crohn's disease is a non-specific intestinal inflammatory disease. The clinical manifestations, laboratory examinations, and imaging examinations of IMT are not specific, making diagnosis difficult. A case of Crohn's disease combined with IMT of abdominal wall was admitted to the Department of Gastroenterology at the Third Xiangya Hospital, Central South University, on Nov. 21, 2017. This patient was admitted to our hospital because of repeated right lower abdominal pain for 4 years. A 6 cm×5 cm mass was palpated in the right lower abdomen. After completing the transanal double-balloon enteroscopy and computed tomographic enterography for the small intestinal, the cause was still unidentified. The patient underwent surgery due to an abdominal wall mass with intestinal fistula on Sept. 12, 2018 and recovered well currently. According to histopathology and immunohistochemistry, he was diagnosed with Crohn's disease combined with IMT. Up to July 2020, the patients still took azathioprine regularly, without abdominal pain, abdominal distension, and other discomfort, and the quality of his life was good.